Brown Virtual Lab
Research project management
Brown Virtual LabSite home

GLP-1 Education · 069

Recognize Confounding by Indication in GLP-1 Research

Confounding by indication occurs when the reason for receiving treatment also relates to the outcome.

Researchers, clinicians, and research learners · October 6, 2026

Dr. Sherry-Ann Brown, MD, PhD, FACC, FAHA

The research question

Confounding by indication occurs when the reason for receiving treatment also relates to the outcome. Disease severity, prior treatment response, weight trajectory, and cardiovascular history may influence prescribing. Access and preference can add further differences. Researchers need to describe these influences when building a comparative observational study.

How to interpret the evidence

An active comparator can improve the clinical relevance of a comparison when both treatments address a similar decision. A new-user design helps align entry with treatment initiation. Investigators also need clearly measured baseline variables and appropriate analytic methods. Residual uncertainty remains part of the result, particularly when important clinical characteristics are poorly captured in records.

The retrospective GLP-1 hair loss cohort provides a relevant study design to examine critically. The design suggestions in this article are original methodological teaching.

Covariate measurement should precede the exposure when the analysis intends to adjust for baseline confounding. A variable affected by treatment may play a different causal role. The research question guides that distinction. A clinical and statistical design discussion can clarify which factors belong in the baseline model and which require another analytic approach.

Practice the appraisal

Original design exercise: list the reasons a clinician might choose one metabolic therapy over another. Separate factors recorded reliably in a dataset from factors often captured in free text or omitted. Consider prior gastrointestinal intolerance, patient goals, insurance rules, and disease severity as hypothetical examples. Check whether the observational study measured these before treatment began. Ask how an active comparator changes the clinical decision being represented. Finish by writing the clearest limitation arising from treatment selection and one feasible improvement for a future study.

Apply the lesson

When planning a cohort, invite a clinician familiar with prescribing decisions to review the covariate list. Clinical insight can reveal treatment-selection factors that a database dictionary may obscure. Examine whether those factors are measured before treatment begins and whether their quality is adequate. The resulting manuscript should describe the clinical comparison and the remaining uncertainty in language that readers can follow.

Sources

  1. Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study

Sources consulted October 6, 2026. Evidence interpretation and proposed exercises are identified in the text.

PURPOSE IN PRACTICE

Develop people while developing evidence.

The laboratory joins rigorous inquiry, distributed leadership, peer learning, transparent contribution, mentorship, and scholarly work that prepares future researchers to serve well.

Awaken the heartClarify purposeSteward giftsDevelop peopleMultiply influence